Acute and Chronic Effects of Aerobic Exercise on Circulating T-Cell Phenotypes and Mitochondrial Bioenergetics in Colorectal Cancer Survivors: A Pilot Ancillary Study of a Randomized Trial

For people who have survived colorectal cancer, the path to long-term health often includes a simple, powerful recommendation: move your body. Regular physical activity is known to improve survival rates, yet the biological reasons why remain somewhat of a mystery. Scientists suspect that exercise acts as a reset button for the immune system, particularly for T-cells, which are the body's specialized soldiers that patrol the blood to find and destroy abnormal cells. As people age, or after they have undergone harsh cancer treatments like chemotherapy, these soldiers can become fewer in number or less effective, a state known as immunosenescence. The question researchers have long asked is whether the simple act of moving can wake up these dormant defenses. Does a single workout immediately mobilize these cells? And does sticking to a regular exercise routine over months actually change the fundamental nature of the immune system, making it stronger and more resilient against the return of disease?

To answer these questions, a team of scientists conducted a focused study with twenty colorectal cancer survivors who had finished their primary treatment. The researchers wanted to see what happened to the immune system in two different timeframes: the immediate reaction to a single workout and the long-term changes after twelve weeks of training. They recruited participants who were generally sedentary and split them into two groups. One group began a program of moderate-intensity walking on a treadmill, gradually building up to nearly four hours of exercise per week. The other group performed a stretching routine, which served as a control to ensure that any changes were due to the aerobic effort of walking rather than just the act of moving or the attention from the research team. Before the program started, and again after it finished, every participant underwent a specific test. They walked on a treadmill at a steady, brisk pace for a short period. The researchers drew blood samples from each person just before they started walking and immediately after they finished. This allowed the team to compare the immune system at rest versus in action, and to see if the twelve-week training program had altered how the body responded to that single bout of exercise.

The results of the single workout were striking and consistent with what is seen in healthy people. The moment the participants finished their brisk walk, their blood showed a significant surge in the number of T-cells. This increase was not limited to one type of soldier; the counts went up for nearly every category of T-cell measured, including the fresh recruits, the experienced veterans, and the older, more specialized cells. The researchers also looked at the energy engines inside these cells, known as mitochondria, which power the immune system's ability to fight. They found that while the internal power of each individual cell did not change, the total energy capacity of the blood increased dramatically. This happened because the sheer number of cells circulating in the blood had risen. It is similar to a city where the power plant in every house stays the same size, but suddenly thousands of new houses are connected to the grid, causing the total electricity available to the entire city to spike. In this case, the exercise had mobilized the immune cells from the edges of blood vessels into the main flow, making the body's defense system much more robust in the immediate aftermath of the workout.

However, the story changed when the researchers looked at the long-term effects of the twelve-week training program. Despite the participants in the walking group sticking to their routine with high adherence, the study found no significant difference between the walkers and the stretchers when it came to their resting immune systems. The training did not increase the number of T-cells sitting in the blood while the participants were at rest, nor did it change the types of cells present or their internal energy capabilities. Furthermore, the twelve weeks of training did not make the immune system respond any differently to the final workout test. The surge of cells and the boost in energy capacity seen after the first workout were just as strong after the twelfth week, but the training itself had not amplified this effect or made the resting immune system fundamentally different. The study suggests that the primary benefit of exercise for these survivors may not be a permanent restructuring of the immune army, but rather the repeated, acute mobilization of these cells every time they move.

The researchers emphasize that this was a small pilot study, meaning the findings are a starting point for larger investigations rather than a final conclusion. They noted that while the immediate response to exercise was clear and measurable, the lack of long-term change could be due to the specific history of the participants, many of whom had undergone treatments that might limit how much their immune systems can adapt. The study confirms that colorectal cancer survivors retain the ability to mobilize their immune defenses through exercise, just like healthy individuals, but it also suggests that the body does not necessarily "rewire" itself to stay in that heightened state without the continuous stimulus of movement. The key takeaway is that the act of exercising itself is the trigger, and the benefits likely come from doing it repeatedly, rather than from a one-time transformation of the immune system's baseline state.